Lentivirus-HLA-B27 mab (59LP) WT Cas9-NAT2 for B Cell Engineering (CAT#: BGS-0524-CR221)

The product is a highly efficient, inducible WT Cas9-NAT2 gene-editing based novel Lentivirus packaging system that can be used to mediate researches involving anti-HLA-B27 mab (59LP) in Murine B cell engineering.

Datasheet

Specifications

Clone 59LP
Host Human
Packaging Cell Line HEK 293T
Vector Promoter HCV
Rep Rep78
Capsid P24
Envelope GP160
Matrix N-terminal
Size ~24kb
Genome dsRNA
Virus Type Lentivirus
Cofactor Requirement No dNTPs
Particles/mL 9.2 × 10¹¹
PFU/mL 9.1 × 10¹¹
TU/mL 3.7 × 10¹¹
Cas9 WT Cas9
sgRNA NAT2
Engineered B Cell Murine B cells

Target Information

Target HLA-B27
Alternative Names HLA-B27; Human Leukocyte Antigen B27

Product Properties

Format Liquid
Shipping The product is shipped by dry ice.
Storage Upon receipt, store immediately at -80°C or lower for long-term storage. Avoid freeze/thaw cycles.
COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number
! For Research Use Only | Not For Clinical Use

Related products